In conversation with WIRED

Professor Mark Kendall’s inventions have drawn attention from some of the world’s biggest names. Think the World Health Organization, the Bill & Melinda Gates Foundation and F1 Grand Prix winner Mark Webber.

The backing of a proven sporting degree

Mark Webber

WearOptimo is proud to count Mark Webber AO as an investor and strategic partner. The Formula 1 champion and endurance athlete came on board after meeting WearOptimo founder and CEO Professor Mark Kendall through a mutual association with luxury watch brand Rolex.

A critical conversation with Planet Hope

Cardiovascular disease is the biggest killer on the planet, claiming more than 30 million lives annually. It’s a horrifying statistic. One made even more so when you consider that all too often – especially with heart attacks – treatment could be as simple as taking an aspirin. If only the victim had more time to act.

Trials attract national attention

In recognition of the start of human trials for our hydration Microwearable sensor, WearOptimo has been the subject of a special 9 News feature.

“We could lead the world if the right projects receive the right funding”

WearOptimo was included in a recent Top Story by Lynne Minion of the online newspaper Healthcare IT. The article, titled “We could lead the world”: Australia’s MTP sector shows it’s punching above its weight” showcased the 11 visionary healthcare projects selected for support in the BioMedTech Horizons funding stream, administered by MTPConnect.

WearOptimo founder and CEO Mark Kendall on The MTPConnect Podcast

Today, the Australian Government announced a $150 million injection for the establishment of the Stem Cell Mission to boost health and medical research in Australia. The announcement was made by the Minister for Health Hon. Greg Hunt MP – MTPConnect was on hand for the big news and to catch up with the Mission’s Co-Chairs Professor Melissa Little and Professor Mark Kendall.